Gastric emptying before and after liver transplantation for familial amyloidotic polyneuropathy, Portuguese type (Val30Met)

References

• Suhr O B, Herlenius G, Friman S, Ericzon B G. Liver transplantation for hereditary transthyretin amyloidosis. Liver Transpl 2000; 6: 263–276
   PubMed Web of Science ®Google Scholar
• Adams D, Samuel D, Goulon‐Goeau C, Nakazato M, Costa P M, Feray C, Plante V, Ducot B, Ichai P, Lacroix C, Metral S, Bismuth H, Said G. The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain 2000; 123(Pt 7)1495–1504
   PubMed Web of Science ®Google Scholar
• Bergethon P R, Sabin T D, Lewis D, Simms R W, Cohen A S, Skinner M. Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation. Neurology 1996; 47: 944–951
   PubMed Web of Science ®Google Scholar
• Ikeda S, Takei Y, Yanagisawa N, Matsunami H, Hashikura Y, Ikegami T, Kawasaki S. Peripheral nerves regenerated in familial amyloid polyneuropathy after liver transplantation. Ann Intern Med 1997; 127: 618–620
   PubMed Web of Science ®Google Scholar
• Parrilla P, Ramirez P, Andreu L F, Bueno S F, Robles R, Miras M, Acosta F, de Viader‐Farre D, Mingo P, Bermejo J, Garrido S F, Munar‐Ques M. Long‐term results of liver transplantation in familial amyloidotic polyneuropathy type I. Transplantation 1997; 64: 646–649
   PubMed Web of Science ®Google Scholar
• Suhr O B, Holmgren G, Steen L, Wikstrom L, Norden G, Friman S, Duraj F F, Groth C G, Ericzon B G. Liver transplantation in familial amyloidotic polyneuropathy. Follow‐up of the first 20 Swedish patients. Transplantation 1995; 60: 933–938
   PubMed Web of Science ®Google Scholar
• Suhr O B, Ericzon B G, Friman S. Long‐term follow‐up of survival of liver transplant recipients with familial amyloid polyneuropathy (Portuguese type). Liver Transpl 2002; 8: 787–794
   PubMed Web of Science ®Google Scholar
• Lobato L, Beirao I, Guimaraes S M, Droz D, Guimaraes S, Grunfeld J P, Noel L H. Familial amyloid polyneuropathy type I (Portuguese): distribution and characterization of renal amyloid deposits. Am J Kidney Dis 1998; 31: 940–946
   PubMed Web of Science ®Google Scholar
• Eriksson P, Karp K, Bjerle P, Olofsson B O. Disturbances of cardiac rhythm and conduction in familial amyloidosis with polyneuropathy. Br Heart J 1984; 51: 658–662
   PubMedGoogle Scholar
• Sandgren O. Ocular amyloidosis, with special reference to the hereditary forms with vitreous involvement. Surv Ophthalmol 1995; 40: 173–196
   PubMed Web of Science ®Google Scholar
• Steen L, Ek B. Familial amyloidosis with polyneuropathy. A long‐term follow‐up of 21 patients with special reference to gastrointestinal symptoms. Acta Med Scand 1983; 214: 387–397
   PubMedGoogle Scholar
• Suhr O, Danielsson A, Holmgren G, Steen L. Malnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloidotic polyneuropathy. J Intern Med 1994; 235: 479–485
   PubMed Web of Science ®Google Scholar
• Suhr O, Danielsson A, Rydh A, Nyhlin N, Hietala S O, Steen L. Impact of gastrointestinal dysfunction on survival after liver transplantation for familial amyloidotic polyneuropathy. Dig Dis Sci 1996; 41: 1909–1914
   PubMed Web of Science ®Google Scholar
• Anan I, El‐Salhy M, Ando Y, Forsgren S, Nyhlin N, Terazaki H, Sakashita N, Suhr O B. Colonic enteric nervous system in patients with familial amyloidotic neuropathy. Acta Neuropathol (Berl) 1999; 98: 48–54
   PubMed Web of Science ®Google Scholar
• Anan I, El‐salhy M, Ando Y, Terazaki H, Suhr O B. Comparison of amyloid deposits and infiltration of enteric nervous system in the upper with those in the lower gastrointestinal tract in patients with familial amyloidotic polyneuropathy. Acta Neuropathol (Berl) 2001; 102: 227–232
   PubMed Web of Science ®Google Scholar
• Anan I, El‐Salhy M, Ando Y, Nyhlin N, Terazaki H, Sakashita N, Suhr O. Colonic endocrine cells in patients with familial amyloidotic polyneuropathy. J Intern Med 1999; 245: 469–473
   PubMed Web of Science ®Google Scholar
• el‐Salhy M, Suhr O, Stenling R, Wilander E, Grimelius L. Impact of familial amyloid associated polyneuropathy on duodenal endocrine cells. Gut 1994; 35: 1413–1418
   PubMed Web of Science ®Google Scholar
• Lång K, Wikström L, Danielsson A R, Tashima K, Suhr O B. Outcome of gastrointestinal complications after liver transplantation for familial amyloidotic polyneuropathy. Scand J Gastroenterol 2000; 35: 985–989
   PubMed Web of Science ®Google Scholar
• Gryback P, Hermansson G, Lyrenas E, Beckman K W, Jacobson H, Hellstrom P M. Nationwide standardisation and evaluation of scintigraphic gastric emptying: reference values and comparisons between subgroups in a multicentre trial. Eur J Nucl Med 2000; 27: 647–655
   PubMedGoogle Scholar
• Kassander P. Asymptomatic gastric retention in diabetes patients (gastroparesis diabeticorum). Ann Intern Med 1958; 48: 789–812
   Web of Science ®Google Scholar
• Takei Y, Ikeda S, Hashikura Y, Ikegami T, Kawasaki S. Partial‐liver transplantation to treat familial amyloid polyneuropathy: follow‐up of 11 patients. Ann Intern Med 1999; 131: 592–595
   PubMed Web of Science ®Google Scholar
• Olofsson B O, Suhr O, Niklasson U, Wiklund U, Bjerle P, Beckman A. Assessment of autonomic nerve function in familial amyloidotic polyneuropathy: a clinical study based on spectral analysis of heart rate variability. Amyloid: Int J Exp Clin Invest 1994; 1: 138–142
   Google Scholar
• Anan I, El‐Salhy M, Nyhlin N, Suhr O B. Liver transplantation restores endocrine cells in patients with familial amyloidotic polyneuropathy. Transplantation 2000; 70: 794–799
   PubMed Web of Science ®Google Scholar
• Stacher G, Schernthaner G, Francesconi M, Kopp H P, Bergmann H, Stacher‐Janotta G, Weber U. Cisapride versus placebo for 8 weeks on glycemic control and gastric emptying in insulin‐dependent diabetes: a double blind cross‐over trial. J Clin Endocrinol Metab 1999; 84: 2357–2362
   PubMed Web of Science ®Google Scholar
• Braden B, Enghofer M, Schaub M, Usadel K H, Caspary W F, Lembcke B. Long‐term cisapride treatment improves diabetic gastroparesis but not glycaemic control. Aliment Pharmacol Ther 2002; 16: 1341–1346
   PubMed Web of Science ®Google Scholar